Back to resultsIV Cocaine Abuse: A Laboratory Model - 3
Primary Purpose
Cocaine-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Buprenorphine
Sponsored by
About this trial
This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring intravenous abuse
Eligibility Criteria
Please contact site for information.
Sites / Locations
- Columbia University
Outcomes
Primary Outcome Measures
Direct cocaine effects (caridio, subjective)
Interaction of coc/bup on cardio measures
Ineraction of coc/bup on coc's subjective effects
Effects of buprenorphine on cocaine craving
Secondary Outcome Measures
Full Information
NCT ID
NCT00000214
First Posted
September 20, 1999
Last Updated
August 27, 2015
Sponsor
New York State Psychiatric Institute
Collaborators
National Institute on Drug Abuse (NIDA), Columbia University
1. Study Identification
Unique Protocol Identification Number
NCT00000214
Brief Title
IV Cocaine Abuse: A Laboratory Model - 3
Official Title
IV Cocaine Abuse: A Laboratory Model
Study Type
Interventional
2. Study Status
Record Verification Date
December 2012
Overall Recruitment Status
Completed
Study Start Date
January 1992 (undefined)
Primary Completion Date
January 1993 (Actual)
Study Completion Date
January 1993 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
New York State Psychiatric Institute
Collaborators
National Institute on Drug Abuse (NIDA), Columbia University
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to evaluate the effects of buprenorpine on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders
Keywords
intravenous abuse
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Buprenorphine
Primary Outcome Measure Information:
Title
Direct cocaine effects (caridio, subjective)
Title
Interaction of coc/bup on cardio measures
Title
Ineraction of coc/bup on coc's subjective effects
Title
Effects of buprenorphine on cocaine craving
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard Foltin, Ph.D.
Organizational Affiliation
Columbia University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Columbia University
City
New York
State/Province
New York
ZIP/Postal Code
10023
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
11224254
Citation
Foltin RW, Fischman MW. Effects of buprenorphine on the self-administration of cocaine by humans. Behav Pharmacol. 1994 Feb;5(1):79-89. doi: 10.1097/00008877-199402000-00009.
Results Reference
background
Learn more about this trial
IV Cocaine Abuse: A Laboratory Model - 3
We'll reach out to this number within 24 hrs